What to Anticipate From Pulse Pressure Amplification

Journal of the American College of Cardiology

Volumn 55, Issue 10, 2010, Pages 1038-1040

  Papaioannou, Theodore G ^a   Protogerou, Athanase D ^b   Stefanadis, Christodoulos ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b SOTIRIA GENERAL HOSPITAL   (Greece)

Author keywords

arterial stiffness; cardiovascular risk; central pressures; hypertension; wave reflections

Indexed keywords

BIOLOGICAL MARKER;

AORTA; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; DIASTOLIC BLOOD PRESSURE; EDITORIAL; HEART; MEAN ARTERIAL PRESSURE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULSE PRESSURE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY HEIGHT; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RISK ASSESSMENT; SEX FACTORS; VASCULAR RESISTANCE; YOUNG ADULT;

EID: 77649142145     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.09.063     Document Type: Editorial

References (9)

1. Avolio A., Van Bortel L., Boutouyrie P., et al. The role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the Data. Hypertension 54 (2009) 375-383
2. Benetos A., Thomas F., and Joly L. Pulse pressure amplification: a mechanical biomarker of cardiovascular risk. J Am Coll Cardiol 55 (2010) 1032-1037
3. Papaioannou T.G., Protogerou A.D., Stamatelopoulos K.S., Vavuranakis M., and Stefanadis C. Non-invasive methods and techniques for central blood pressure estimation: procedures, validation, reproducibility and limitations. Curr Pharm Des 15 (2009) 245-253
4. Segers P., Mahieu D., Kips J., et al., Aslepios Investigators. Amplification of the pressure pulse in the upper limb in healthy, middle-aged men and women. Hypertension 54 (2009) 414-420
5. McEniery C.M., Yasmin, McDonnell B., et al. Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II. Hypertension 51 (2008) 1476-1482
6. Protogerou A.D., Papaioannou T.G., Blacher J., Papamichael C., Lekakis J., and Safar M. Central blood pressure: do we need them in the management of cardiovascular disease?. Is it a feasible therapeutic target?. J Hypertens 25 (2007) 265-272
7. Protogerou A.D., Stergiou G.S., Vlachopoulos C., Blacher J., and Achimastos A. The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: evidence for specific class-effects of antihypertensive drugs on pressure amplification. Curr Pharm Des 15 (2009) 272-289
8. Safar M.E., Blacher J., Pannier B., et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension 39 (2002) 735-738
9. Hashimoto J., Imai Y., and O'Rourke M.F. Monitoring of antihypertensive therapy for reduction in left ventricular mass. Am J Hypertens 20 (2007) 1229-1233